Lorrach, Germany

Andreas Rummelt

This inventor holds 1 USPTO granted patent. Top assignee: Sandoz Gmbh. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Rummelt. Retrieved from https://idiyas.com/inventor/andreas-rummelt-ixpnv8ia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andreas Rummelt: Innovator in Pulmonary Administration

Introduction

Andreas Rummelt is a notable inventor based in Lorrach, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of pulmonary administration of medications.

Latest Patents

Rummelt holds a patent for a unique formulation of Ciclosporin designed for pulmonary administration. This patent details the orthorhombic crystal form of Ciclosporin, designated as 'CY-A/X-III'. It is intended for the treatment of obstructive or inflammatory airway diseases, such as asthma. The patent also covers the preparation processes and pharmaceutical uses of crystalline Ciclosporin in spheroidal particulate form, as well as its application in aerosol propellants.

Career Highlights

Andreas Rummelt is associated with Sandoz GmbH, a leading company in the pharmaceutical industry. His work focuses on innovative drug delivery systems that enhance the efficacy of treatments for respiratory conditions.

Collaborations

Rummelt has collaborated with esteemed colleagues, including John Morley and Martin List, to advance research and development in his field.

Conclusion

Andreas Rummelt's contributions to the pharmaceutical industry, particularly through his patent on Ciclosporin for pulmonary administration, highlight his role as an innovator in improving treatment options for respiratory diseases. His work continues to influence the development of effective therapies in this critical area of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…